Your browser doesn't support javascript.
loading
Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity.
Wang, Wanqiao; Li, Xin; Qin, Xia; Miao, Yan; Zhang, Yingwen; Li, Shanshan; Yao, Ruen; Yang, Yi; Yu, Lisha; Zhu, Hua; Song, Lili; Mao, Shengqiao; Wang, Xiumin; Chen, Jing; Feng, Haizhong; Li, Yanxin.
Afiliação
  • Wang W; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology & Oncology of China Ministry of Health, Shanghai, China.
  • Li X; Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai, China.
  • Qin X; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Miao Y; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Zhang Y; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li S; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology & Oncology of China Ministry of Health, Shanghai, China.
  • Yao R; Department of Medical Genetics, Shanghai Children's Medical Center, Shanghai, China.
  • Yang Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology & Oncology of China Ministry of Health, Shanghai, China.
  • Yu L; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Zhu H; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Song L; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Mao S; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Wang X; Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai, China.
  • Chen J; Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China.
  • Feng H; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Pediatric Hematology & Oncology of China Ministry of Health, Shanghai, China.
Br J Haematol ; 202(2): 328-343, 2023 07.
Article em En | MEDLINE | ID: mdl-37144690
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Leucemia Mielomonocítica Juvenil Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Leucemia Mielomonocítica Juvenil Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article